期刊文献+

肝衰竭患者外周血单核细胞HLA-DR的表达

Expression of HLA-DR mRNA from peripheral blood mononuclear cells in patients with liver failure
下载PDF
导出
摘要 目的探讨不同病因所致肝衰竭患者外周血单核细胞HLA-DR基因mRNA表达及其意义。方法随机选取肝衰竭患者40例,其中嗜肝病毒感染10例、药物性肝损伤10例、酒精性肝损伤10例、自身免疫性肝病10例。10名健康对照为本院健康志愿者。应用RT-PCR法检测各组患者外周血单核细胞HLA-DR基因mRNA表达,并动态观察HLA-DR基因mRNA表达的变化,及其与病程发展及临床症状的关系。结果 RT-PCR结果显示嗜肝病毒感染组、正常对照组、药物损伤组、酒精损伤组、自身免疫组HLA-DR基因mRNA表达分别为(137.51±5.22)、(18.14±1.29)、(19.64±2.03)、(11.25±1.22)、(26.61±2.31),且呈逐渐降低趋势,组间差异均有统计学意义(P<0.05)。对不同病因组患者单核细胞HLA-DR mRNA表达进行动态观察发现,17例死亡患者HLA-DR mRNA表达持续下降直至患者死亡;另外23例患者,经治疗各组HLA-DR mRNA表达逐渐恢复至接近正常水平,临床症状同步改善。结论外周血单核细胞HLA-DR mRNA表达与肝功能衰竭的严重程度密切相关。 Objective To investigate the HLA-DR mRNA expression from peripheral blood mononuclear cells (PBMCs)of liver failure patients with different pathogenesis.Methods Forty patients with liver failure from 2010 to 2014 in our hospital were enrolled and divided into 4 groups according to pathogenesis. Meanwhile, 10 persons undergoing health examination were involved as control.Expression of HLA-DR mRNA from PBMCs was detected by real time-polymerase chain reaction (RT-PCR)at day 1 ,4,8,12,16,20 after hospitalization,to analyze its relevance with liver failure progress and clinical symptoms.Results There was significant difference in HLA-DR mRNA expressions among 4 groups.The level of HLA-DR mRNA decreased continuously without amelioration in 17 died patients,while that increased gradually to normal level with symptom improved in other 23 survived patients.Conclusion Expression of HLA-DR mRNA from PBMCs is closely related to severity of liver failure,which might be a valuable parameter to evaluate severity and prognosis of liver failure in clinic practice.
出处 《肝脏》 2015年第3期198-200,共3页 Chinese Hepatology
关键词 肝衰竭 实时荧光定量反转录聚合酶链反应 HLA-DR liver failure HLA-DR RT-PCR
  • 相关文献

参考文献11

  • 1中华医学会传染病与寄生虫病学分会、肝病学分会联合修订.病毒性肝炎防治方案.中华传染病杂志,2001,19:56- 62.
  • 2Lin CY,Tsai IF, Ho YP,et al. Endotoxemia contributes to theimmuneparalysis in patients with cirrhosis. J Hepatol, 2007 , 46 :816-826.
  • 3Berres ML, Schnyder B, Yagmur E, et al. Longitudinal monocytehuman leukocyte antigen-DR expression is a prognostic marker incritically ill patients with decompensated liver cirrhosis. Liver Int,2009,29:536-543.
  • 4Berry PA, Antoniades CG, Carey I,et al. Severity of the compensatoryanti-inflammatory response determined by monocyte HLA-DRexpression may assist outcome prediction in cirrhosis. IntensiveCare Med, 2011,37:453-460.
  • 5Raposo G, Moore M, Innes D, et al. Human macrophages accumulateHIV-1 particles in MHC II compartments . Traffle, 2002, 3 : 718-729.
  • 6Soares-Schanoski A,Jurado T, Cordoba R,et al. Impaired antigenpresentation and potent phagocytic activity identifying tumor-tolerant human monocytes. Biochem Biophys Res Commun,2012,423:331-337.
  • 7Wolk K,Kunz S,Crompton NE, et al. Multiple mechanisms ofreduced major histocompatibility complex class IT expression inendotoxin tolerance. J Biol Chem, 2003,278 : 18030-18036.
  • 8Vokl HD,Reink P,Krausch D, et al,Monocyte deactivationrationale for a new therapeutic stratery in sepsis. Intensive CareMed,1996,22: 474-481.
  • 9Abeles RD,McPhail MJ,Sowter D, et al. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in thecontext of pathologically reduced HLA-DR expression by CD14(hi)/CDl6(neg) monocytes: Expansion of CDl4(hi) /CDl6(pos) andcontraction of CD14 (lo) /CD16 ( pos) monocytes in acute liverfailure. Cytometry ,2012,81:823-834.
  • 10林洪远,郭旭生,姚咏明,程尉新,翁志华,韦文韬,盛志勇.CD_(14)^+单核细胞人类白细胞抗原-DR预测脓毒症预后及指导免疫调理治疗的初步临床研究[J].中国危重病急救医学,2003,15(3):135-138. 被引量:100

二级参考文献15

  • 1章云涛,方强.外科术后危重患者单核细胞HLA-DR表达的临床研究[J].中华外科杂志,2006,44(21):1480-1482. 被引量:5
  • 2苏磊,周殿元,唐柚青,文强,白涛,孟繁甦,唐丽群,段鹏凯.乌司他丁联合胸腺肽α_1对脓毒症患者免疫调理的合理性分析[J].解放军医学杂志,2007,32(2):161-163. 被引量:12
  • 3Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS Grit Care Med,1996,24(7) : 1125.
  • 4Bone RG Immunologic dissonance: a continuing evolution in our understanding of systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med, 1996,125(8) :680.
  • 5Heidecke CD, HT WH. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection, Am J Surg, 1999, 178 (4) : 288.
  • 6Weighardt H, Heidecke CD, Emmanuilidis K, et al. Sepsis after major visceral surgery is associated with sustained and interferon γ resistant defects of monocyte cytokine production. Surgery, 2000, 127 (3) : 309.
  • 7Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCAZM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest, 1992, 101(6): 1644.
  • 8Volk HD, Reinke P, Krausch D, et al. monocyte deactivation-rationale for a new therapeutic stragegy in sepsis. Intensive Care Med, 1996,22(11):1.
  • 9Sedlackova L, Prucha M, Dostdl M. Immunological monitoring of sepsis using flow tion of monoeyte HLA-DR expression and granulocyte CD64 expression . Epidemiol Mikrobiol Imunol, 2005, 54(2) :54.
  • 10Venet F, Tissot S, Debard AL, et al. Decreased monocyte human leukocyte antigen-DR expression after severe bum injury: correlation with severity and secondary septic shock. Crit Care Med, 2007, 35 (8) :1910.

共引文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部